Company dedicated to the development of potential therapies for neurodegenerative diseases
| Year | Firm | Period | Expenses | Doc |
|---|---|---|---|---|
| 2022 | TARPLIN, DOWNS & YOUNG, LLC |
4th Quarter (Oct 1 - Dec 31) AMENDED |
— | |
| 2022 | TARPLIN, DOWNS & YOUNG, LLC |
4th Quarter (Oct 1 - Dec 31) 4th Quarter - Report |
— | |
| 2022 | TARPLIN, DOWNS & YOUNG, LLC |
3rd Quarter (July 1 - Sep 30) 3rd Quarter - Report |
— | |
| 2022 | TARPLIN, DOWNS & YOUNG, LLC |
2nd Quarter (Apr 1 - June 30) 2nd Quarter - Report |
— | |
| 2022 | TARPLIN, DOWNS & YOUNG, LLC |
2nd Quarter (Apr 1 - June 30) Registration |
— |
| Firm | Filings | Expenses |
|---|---|---|
| TARPLIN, DOWNS & YOUNG, LLC | 18 | — |
| Issue | Activities |
|---|---|
| Medicare/Medicaid | 18 |
| Health Issues | 18 |